Clinical trial for Atheroscleroses
Official title Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor β
ClinicalTrials.gov ID: NCT07877324
What this study is testing
- What it's testing
- This study investigates inflammation in the blood vessels of people with coronary artery disease (CAD) or a recent myocardial infarction.
- Time commitment: about 5 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- \- Patients aged 50-80 years with suspected coronary artery disease who have undergone coronary CT angiography and are referred for cardiac 15O-water...
- \- Patients aged 50-80 years with a recent myocardial infarction.
- \- Written informed consent.
You likely can't join if
- unstable angina symptoms
- previous myocardial infarction (Group A)
- previous coronary artery bypass grafting or previous percutaneous coronary intervention
- severe pulmonary disease
- severe symptomatic asthma
- severe valvular disease
See the full eligibility criteria
- \- Patients aged 50-80 years with suspected coronary artery disease who have undergone coronary CT angiography and are referred for cardiac 15O-water PET perfusion imaging based on suspected obstructive coronary artery...
- \- Patients aged 50-80 years with a recent myocardial infarction.
- \- Written informed consent.
- unstable angina symptoms
- previous myocardial infarction (Group A)
- previous coronary artery bypass grafting or previous percutaneous coronary intervention
- severe pulmonary disease
- severe symptomatic asthma
- severe valvular disease
- uncontrolled hypertension (\>180/110 mmHg)
- severe hypotension (systolic blood pressure \<100 mmHg)
- severe renal failure
- pregnancy
- age \ 80 years
- second- or third-degree atrioventricular block or sick sinus syndrome without a pacemaker
- allergy to X-ray contrast agents
- known inflammatory disease, including rheumatic or autoimmune disease, sarcoidosis, or myocarditis
- known infection
- use of anti-inflammatory medication or folate antagonists such as corticosteroids or methotrexate; known cancer.
The study team makes the final eligibility decision.
Where it is enrolling
- Turku, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 5 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Turku, Finland. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.